インターベンショナル神経学の世界市場:製品別(動脈瘤コイル塞栓術デバイス、脳バルーン血管形成術&ステントシステム、サポートデバイス、神経血栓摘出デバイス)、疾患病理学別(虚血性脳卒中、脳動脈瘤、動静脈奇形&瘻孔、その他の疾患病理学)

◆英語タイトル:Global Interventional Neurology Market Size study, by Product (Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices) By Disease Pathology (Ischemic Strokes, Cerebral Aneurysms, Arteriovenous Malformation and Fistulas, Other Disease Pathologies) and regional forecasts 2019-2026.
◆商品コード:BZW20FB131
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年1月21日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥675,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、インターベンショナル神経学の世界市場について調べ、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、製品別(動脈瘤コイル塞栓術デバイス、脳バルーン血管形成術&ステントシステム、サポートデバイス、神経血栓摘出デバイス)分析、疾患病理学別(虚血性脳卒中、脳動脈瘤、動静脈奇形&瘻孔、その他の疾患病理学)分析、地域別分析、競争状況などで構成されています。
・エグゼクティブサマリー
・市場の定義・範囲
・市場動向
・産業分析
・インターベンショナル神経学の世界市場:製品別(動脈瘤コイル塞栓術デバイス、脳バルーン血管形成術&ステントシステム、サポートデバイス、神経血栓摘出デバイス)
・インターベンショナル神経学の世界市場:疾患病理学別(虚血性脳卒中、脳動脈瘤、動静脈奇形&瘻孔、その他の疾患病理学)
・インターベンショナル神経学の世界市場:地域別
・競争状況
【レポートの概要】

Global Interventional Neurology Market is valued approximately at USD 2.1 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.60% over the forecast period 2019-2026. Interventional neurology is the novel procedure adopted for the non-surgical treatment in neurological diseases. Interventional neurology has wide range of application in the diagnosis of peripheral systems and nervous system. Large target patient population, ongoing product development and commercialization and favorable medical reimbursements are key driving forces of market growth. As per the World Health Organization, Neurological disorder accounts for 6.3% of the global diseases burden. According to the European Academy of Neurology, in 2018, about 220.7 million people in Europe suffer from neurological diseases. In addition, expansion of healthcare infrastructure across emerging markets coupled with growing demand for effective neurovascular devices are further contributing towards the market growth. Moreover, increasing research activities in the field of neurovascular therapies and rising demand for minimally invasive neurosurgical procedures is expected to create significant growth opportunity in the market over the forecast period. According to the Indian Brand Equity Foundation, in 2018, with the rising cases of neurological disorder government spend about USD 1.14 billion for the treatment and providing awareness of CNS disorders. Also, In United States the total spending on mental health treatment accounts for 2.4% of total government health spending along with the median allocation of fund in the psychiatric hospital by government is 80% of total government health spending. However, Stringent regulations and lack of skilled Neurosurgeons impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global interventional Neurology market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing geriatric population, high purchasing power coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising geriatric population, growing disposable income, rising incidences of neurological diseases and improving healthcare infrastructure would create lucrative growth prospects for the Interventional Neurology market across Asia-Pacific region.

Major market player included in this report are:
Stryker Corporation
Medtronic PLC
Johnson & Johnson
Terumo Corporation
Penumbra, Inc.
Boston Scientific Corporation
Microport Scientific Corporation
Merit Medical Systems, Inc.
W.L. Gore & Associates, Inc.
Abbott Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Aneurysm Coiling & Embolization Devices
Cerebral Balloon Angioplasty and Stenting Systems
Support Devices
Neurothrombectomy Devices

By Disease Pathology:
Ischemic Strokes
Cerebral Aneurysms
Arteriovenous Malformation and Fistulas
Other Disease Pathologies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Interventional Neurology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Interventional Neurology Market, by Region, 2017-2026 (USD Billion)
1.2.2. Interventional Neurology Market, by Product, 2017-2026 (USD Billion)
1.2.3. Interventional Neurology Market, by Disease Pathology, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Interventional Neurology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Interventional Neurology Market Dynamics
3.1. Interventional Neurology Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Interventional Neurology Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Interventional Neurology Market, by Product
5.1. Market Snapshot
5.2. Global Interventional Neurology Market by Product, Performance – Potential Analysis
5.3. Global Interventional Neurology Market Estimates & Forecasts by Product 2016-2026 (USD Billion)
5.4. Interventional Neurology Market, Sub Segment Analysis
5.4.1. Aneurysm Coiling & Embolization Devices
5.4.2. Cerebral Balloon Angioplasty and Stenting Systems
5.4.3. Support Devices
5.4.4. Neurothrombectomy Devices
Chapter 6. Global Interventional Neurology Market, by Disease Pathology
6.1. Market Snapshot
6.2. Global Interventional Neurology Market by Disease Pathology, Performance – Potential Analysis
6.3. Global Interventional Neurology Market Estimates & Forecasts by Disease Pathology 2016-2026 (USD Billion)
6.4. Interventional Neurology Market, Sub Segment Analysis
6.4.1. Ischemic Strokes
6.4.2. Cerebral Aneurysms
6.4.3. Arteriovenous Malformation and Fistulas
6.4.4. Other Disease Pathologies
Chapter 7. Global Interventional Neurology Market, Regional Analysis
7.1. Interventional Neurology Market, Regional Market Snapshot
7.2. North America Interventional Neurology Market
7.2.1. U.S. Interventional Neurology Market
7.2.1.1. Product breakdown estimates & forecasts, 2016-2026
7.2.1.2. Disease Pathology breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Interventional Neurology Market
7.3. Europe Interventional Neurology Market Snapshot
7.3.1. U.K. Interventional Neurology Market
7.3.2. Rest of Europe Interventional Neurology Market
7.4. Asia-Pacific Interventional Neurology Market Snapshot
7.4.1. China Interventional Neurology Market
7.4.2. India Interventional Neurology Market
7.4.3. Japan Interventional Neurology Market
7.4.4. Rest of Asia Pacific Interventional Neurology Market
7.5. Latin America Interventional Neurology Market Snapshot
7.5.1. Brazil Interventional Neurology Market
7.5.2. Mexico Interventional Neurology Market
7.6. Rest of The World Interventional Neurology Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Stryker Corporation
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Medtronic PLC
8.2.3. Johnson & Johnson
8.2.4. Terumo Corporation
8.2.5. Penumbra, Inc.
8.2.6. Boston Scientific Corporation
8.2.7. Microport Scientific Corporation
8.2.8. Merit Medical Systems, Inc.
8.2.9. W.L. Gore & Associates, Inc.
8.2.10. Abbott Laboratories
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL INTERVENTIONAL NEUROLOGY MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL INTERVENTIONAL NEUROLOGY MARKET
TABLE 3. GLOBAL INTERVENTIONAL NEUROLOGY MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)
TABLE 8. GLOBAL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY DISEASE PATHOLOGY 2016-2026 (USD BILLION)
TABLE 9. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL INTERVENTIONAL NEUROLOGY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW INTERVENTIONAL NEUROLOGY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[インターベンショナル神経学の世界市場:製品別(動脈瘤コイル塞栓術デバイス、脳バルーン血管形成術&ステントシステム、サポートデバイス、神経血栓摘出デバイス)、疾患病理学別(虚血性脳卒中、脳動脈瘤、動静脈奇形&瘻孔、その他の疾患病理学)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆